Alexion Pharma (ALXN) Tops Q3 EPS by 32c, Raises FY Guidance
Tweet Send to a Friend
Alexion Pharma (NASDAQ: ALXN) reported Q3 EPS of $2.79, $0.32 better than the analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
